There are a plethora of epidemiological studies linking uric acid with incident hypertension [1][2][3][4] and with cardiovascular events. 5 Some studies have shown a sex difference in cardiovascular events with the adverse cardiovascular association of uric acid seen only in women. [6][7][8] There is convincing evidence from animal studies that elevated uric acid has a detrimental effect on blood pressure (BP) and renal function. Administration of uric acid causes a rise in arterial BP in rat models 9 and sustained elevation of uric acid results in salt-sensitive hypertension and irreversible renal damage characterized by both arteriolar and glomerular damage. 10 Furthermore, the xanthine oxidase inhibitor allopurinol lowers BP in adolescents with hypertension and hyperuricemia 11 and both allopurinol and the uricosuric drug probenecid lower BP in obese adolescents with prehypertension. 12 A recent meta-analysis found that allopurinol lowers BP by 3/2 mm Hg in adults, 13 although this has never been tested in a specifically designed prospective study. Despite these results, there is still debate about a causal role for uric acid and the potential cardiovascular benefits of allopurinol may reflect either uric acid reduction or other mechanisms, such as superoxide anion reduction. 14 The association of uric acid with BP and kidney function suggests that uric acid levels may have implications in the clinical management of hypertension. The aim of this study is to determine whether baseline uric acid level, in patients attending a hypertension clinic, is associated with longitudinal BP level, renal function, and long-term cause-specific mortality in a sex-specific manner.
Methods
Study Setting and Study PopulationWe performed an analysis of longitudinal BP control, change in renal function, and long-term cause-specific mortality using data from the Glasgow Blood Pressure Clinic (GBPC).Abstract-Uric acid may have a role in the development of hypertension and renal dysfunction. We explored the relationship among longitudinal blood pressure, renal function, and cardiovascular outcomes in a large cohort of patients with treated hypertension. We used data from the Glasgow Blood Pressure Clinic database. Patients with a baseline measure of serum uric acid and longitudinal measures of blood pressure and renal function were included. Mortality data were obtained from the General Register Office for Scotland. Generalized estimating equations were used to explore the relationship among quartiles of serum uric acid, blood pressure, and estimated glomerular filtration rate. Cox proportional hazard models were developed to assess mortality relationships. In total, 6984 patients were included. Serum uric acid level did not influence the longitudinal changes in systolic or diastolic blood pressure but was related to change in glomerular filtration rate. In comparison with patients in the first quartile of serum uric acid, the relative decrease in glomerular filtration rate in the fourth was 10.7 (95% confidence interval, 7.9-13.6 ...